PURPOSE: Evidence suggests that plasma retinol-binding protein 4 (RBP4) and insulin resistance are related to body fat (BF). We aimed to assess the relationship between RBP4 and insulin resistance with obesity in a mixed (skin color) cohort of the Brazilian population. METHODS: A nested case-control study was conducted in 227 schoolchildren aged 7-14 years. Schoolchildren with a high BF percentage (% BF, ≥ 30 for girls and ≥ 25 for boys) were identified as the obese group (n = 137), and those with lower values were identified as the non-obese group (n = 90). Percentage of body fat (% BF) was determined by tetrapolar bioimpedance (Quantum II, RJL System), RBP4 by enzyme-linked immunosorbent assay (Immunology Consultants Laboratory), plasma fasting insulin by chemiluminescent immunoassay (Access(®) Immunoassay System) and insulin resistance by the homeostasis model insulin resistance (IR(HOMA)) index. Serum lipid profile and arterial blood pressure were evaluated. RESULTS: The significant independent risk factors associated with obesity were as follows: male sex, increased serum LDL-C, RBP4 and IR(HOMA). Among children with higher RBP4, the association with obesity increased significantly (from 3.1 to 8.5) in the presence of insulin resistance, when compared to higher RBP4 and non-insulin resistance. CONCLUSION: IR(HOMA) and RBP4 showed significant associations with obesity and traditional CVD risk factors. They might therefore be used as a marker for CVD risk and have clinical implications in the development of comorbidities associated with obesity.
PURPOSE: Evidence suggests that plasma retinol-binding protein 4 (RBP4) and insulin resistance are related to body fat (BF). We aimed to assess the relationship between RBP4 and insulin resistance with obesity in a mixed (skin color) cohort of the Brazilian population. METHODS: A nested case-control study was conducted in 227 schoolchildren aged 7-14 years. Schoolchildren with a high BF percentage (% BF, ≥ 30 for girls and ≥ 25 for boys) were identified as the obese group (n = 137), and those with lower values were identified as the non-obese group (n = 90). Percentage of body fat (% BF) was determined by tetrapolar bioimpedance (Quantum II, RJL System), RBP4 by enzyme-linked immunosorbent assay (Immunology Consultants Laboratory), plasma fasting insulin by chemiluminescent immunoassay (Access(®) Immunoassay System) and insulin resistance by the homeostasis model insulin resistance (IR(HOMA)) index. Serum lipid profile and arterial blood pressure were evaluated. RESULTS: The significant independent risk factors associated with obesity were as follows: male sex, increased serum LDL-C, RBP4 and IR(HOMA). Among children with higher RBP4, the association with obesity increased significantly (from 3.1 to 8.5) in the presence of insulin resistance, when compared to higher RBP4 and non-insulin resistance. CONCLUSION: IR(HOMA) and RBP4 showed significant associations with obesity and traditional CVD risk factors. They might therefore be used as a marker for CVD risk and have clinical implications in the development of comorbidities associated with obesity.
Authors: Isabela de Carlos Back Giuliano; Bruno Caramelli; Lucia Pellanda; Bruce Duncan; Sandra Mattos; Francisco H Fonseca Journal: Arq Bras Cardiol Date: 2005-12 Impact factor: 2.000
Authors: Stephen R Daniels; Marc S Jacobson; Brian W McCrindle; Robert H Eckel; Brigid McHugh Sanner Journal: Circulation Date: 2009-03-30 Impact factor: 29.690
Authors: Ana Paula Carlos Cândido; Silvania Ferreira; Angélica Alves Lima; Roney Luiz de Carvalho Nicolato; Sílvia Nascimento de Freitas; Paulo Brandão; Alexandre Pereira; José Eduardo Krieger; Raimundo Marques do Nascimento-Neto; George Luiz Lins Machado-Coelho Journal: Atherosclerosis Date: 2006-07-14 Impact factor: 5.162
Authors: Ana Paula C Cândido; Raquel Benedetto; Ana Paula P Castro; Joseane S Carmo; Roney L C Nicolato; Raimundo M Nascimento-Neto; Renata N Freitas; Sílvia N Freitas; Waleska T Caiaffa; George L L Machado-Coelho Journal: Eur J Pediatr Date: 2009-02-24 Impact factor: 3.183
Authors: L D Monti; P Brambilla; I Stefani; A Caumo; F Magni; R Poma; L Tomasini; G Agostini; M Galli-Kienle; C Cobelli Journal: Diabetologia Date: 1995-06 Impact factor: 10.122
Authors: Laura Pala; Matteo Monami; Silvia Ciani; Ilaria Dicembrini; Alessandro Pasqua; Anna Pezzatini; Paolo Francesconi; Barbara Cresci; Edoardo Mannucci; Carlo Maria Rotella Journal: J Nutr Metab Date: 2011-08-22